HANALL BIOPHARMA CO.,LTD Stock Price & Chart

KRX: 009420 · 한올바이오파마 · KOSPI

₩47,500▲ ₩900 (+1.93%)at close · July 27, 2026
73,00025,00047,500Jul 03, 25Oct 10Jan 14Apr 20Jul 27, 26

HANALL BIOPHARMA CO.,LTD (한올바이오파마, KRX: 009420) last closed at ₩47,500 on July 27, 2026, a +1.93% move on the day. Over the trailing 52 weeks the stock has traded between ₩25,550 and ₩73,000, a +76.58% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩47,500
Day change+1.93%
52-week high₩73,000
52-week low₩25,550

Key Fundamentals

FY 2026.03
Market cap₩2.48T
P/E (PER)-439.62
P/B (PBR)14.92
EPS₩-106
BPS₩3,184
ROE-3.16%
Debt ratio50.18%
Rev. growth10.73%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.03) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-27
BearishAlgorithmic summary of 5 standard indicators (net score -3). Describes current technical posture only — not a buy or sell recommendation.
  • ▼ Bearish20-day MAPrice below 55,203
  • ▼ Bearish60-day MAPrice below 52,838
  • ▼ Bearish120-day MAPrice below 53,212
  • ▲ BullishMA trend (20 vs 60)Short-term above mid-term
  • · NeutralRSI (14)RSI 37 — neutral zone
  • ▼ BearishMACD (12,26,9)MACD below signal
52-week position: 46% of rangeRSI(14): 375-day volume vs 20-day: -48%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning HANALL BIOPHARMA CO.,LTD

No daily reports have covered HANALL BIOPHARMA CO.,LTD yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.